Lennox International Inc. (NYSE: LII), a leader in energy-efficient climate-control solutions, today announced that CEO Alok Maskara and CFO Joe Reitmeier are scheduled to present at the Baird...

Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that study investigators will present data from the BRUIN Phase 1/2 trial of pirtobrutinib at the American...

The 2nd Global Forum of People's Organizations on Hansen's Disease takes place in Hyderabad, India, from November 6 to 8, 2022. Organized by Sasakawa Leprosy (Hansen's Disease) Initiative as part...

Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,...

Real-world analysis findings highlight overall survival benefit in adolescent and young adult (AYA) newly-diagnosed acute lymphoblastic leukemia (ALL) patients treated with pediatric-inspired...